COVID-19 drug practices risk antimicrobial resistance evolution
Research output: Contribution to journal › Comment/debate › Research › peer-review
Documents
- COVID-19 drug practices risk antimicrobial resistance evolution
Final published version, 193 KB, PDF document
| Original language | English |
|---|---|
| Journal | The Lancet Microbe |
| Volume | 2 |
| Issue number | 4 |
| Pages (from-to) | e135-e136 |
| ISSN | 2666-5247 |
| DOIs |
|
| Publication status | Published - 2021 |
ID: 261376656